tiprankstipranks
Trending News
More News >
WORK Medical Technology Group LTD (WOK)
NASDAQ:WOK
US Market

WORK Medical Technology Group LTD (WOK) Ratios

Compare
23 Followers

WORK Medical Technology Group LTD Ratios

WOK's free cash flow for Q4 2024 was $0.21. For the 2024 fiscal year, WOK's free cash flow was decreased by $ and operating cash flow was $-0.57. See a summary of the company’s cash flow.
Ratios
TTM
Sep 24Sep 23Sep 22Sep 21
Liquidity Ratios
Current Ratio
1.17 1.17 1.17 0.96 0.81
Quick Ratio
0.93 0.93 0.86 0.63 0.55
Cash Ratio
0.08 0.08 0.05 0.03 <0.01
Solvency Ratio
0.09 0.09 0.29 0.53 0.09
Operating Cash Flow Ratio
0.12 0.12 -0.16 -0.38 0.55
Short-Term Operating Cash Flow Coverage
0.25 0.25 -0.36 -1.09 7.86
Net Current Asset Value
$ 3.18M$ 3.18M$ 2.26M$ -1.12M$ -9.90M
Leverage Ratios
Debt-to-Assets Ratio
0.30 0.30 0.25 0.22 0.07
Debt-to-Equity Ratio
0.92 0.92 0.63 0.66 0.83
Debt-to-Capital Ratio
0.48 0.48 0.39 0.40 0.45
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.11
Financial Leverage Ratio
3.03 3.03 2.55 3.05 11.47
Debt Service Coverage Ratio
0.22 0.22 0.69 1.56 1.25
Interest Coverage Ratio
1.32 1.32 5.20 23.29 23.03
Debt to Market Cap
0.17 0.17 0.12 0.13 0.08
Interest Debt Per Share
0.65 0.65 0.46 0.48 0.30
Net Debt to EBITDA
3.60 3.60 1.18 0.51 0.81
Profitability Margins
Gross Profit Margin
30.54%30.54%22.42%18.84%20.65%
EBIT Margin
3.52%3.52%7.43%16.73%3.02%
EBITDA Margin
15.34%15.34%23.96%25.87%9.04%
Operating Profit Margin
3.59%3.59%9.26%16.73%11.40%
Pretax Profit Margin
0.81%0.81%5.65%16.01%2.53%
Net Profit Margin
0.83%0.83%4.39%12.99%2.22%
Continuous Operations Profit Margin
0.47%0.47%4.79%13.66%2.32%
Net Income Per EBT
101.49%101.49%77.70%81.13%87.60%
EBT Per EBIT
22.69%22.69%61.02%95.71%22.18%
Return on Assets (ROA)
0.37%0.37%3.39%19.44%2.07%
Return on Equity (ROE)
1.13%1.13%8.65%59.34%23.75%
Return on Capital Employed (ROCE)
4.41%4.41%16.17%65.36%90.34%
Return on Invested Capital (ROIC)
1.39%1.39%8.83%35.70%54.49%
Return on Tangible Assets
0.39%0.39%3.52%20.13%2.11%
Earnings Yield
0.21%0.21%1.66%11.41%2.23%
Efficiency Ratios
Receivables Turnover
1.23 1.23 3.21 79.29 62.27
Payables Turnover
2.38 2.38 4.77 4.12 3.65
Inventory Turnover
2.04 2.04 3.51 5.91 3.22
Fixed Asset Turnover
2.01 2.01 2.47 4.01 3.55
Asset Turnover
0.45 0.45 0.77 1.50 0.93
Working Capital Turnover Ratio
4.86 4.86 24.87 -9.20 0.00
Cash Conversion Cycle
321.07 321.07 141.44 -22.36 19.19
Days of Sales Outstanding
295.57 295.57 113.86 4.60 5.86
Days of Inventory Outstanding
178.96 178.96 104.02 61.72 113.20
Days of Payables Outstanding
153.46 153.46 76.44 88.68 99.87
Operating Cycle
474.54 474.54 217.88 66.32 119.06
Cash Flow Ratios
Operating Cash Flow Per Share
0.15 0.15 -0.16 -0.50 1.88
Free Cash Flow Per Share
0.11 0.11 -0.29 -0.50 0.67
CapEx Per Share
0.04 0.04 0.14 <0.01 1.21
Free Cash Flow to Operating Cash Flow
0.74 0.74 1.89 1.01 0.35
Dividend Paid and CapEx Coverage Ratio
3.79 3.79 -1.12 -119.64 1.55
Capital Expenditure Coverage Ratio
3.79 3.79 -1.12 -119.64 1.55
Operating Cash Flow Coverage Ratio
0.24 0.24 -0.36 -1.09 6.72
Operating Cash Flow to Sales Ratio
0.16 0.16 -0.11 -0.16 0.52
Free Cash Flow Yield
3.12%3.12%-8.18%-13.87%18.48%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
465.95 465.95 60.33 8.76 44.85
Price-to-Sales (P/S) Ratio
3.85 3.85 2.65 1.14 0.99
Price-to-Book (P/B) Ratio
5.29 5.29 5.22 5.20 10.65
Price-to-Free Cash Flow (P/FCF) Ratio
32.09 32.09 -12.22 -7.21 5.41
Price-to-Operating Cash Flow Ratio
23.62 23.62 -23.11 -7.27 1.92
Price-to-Earnings Growth (PEG) Ratio
-5.35 -5.35 -0.71 0.02 0.00
Price-to-Fair Value
5.29 5.29 5.22 5.20 10.65
Enterprise Value Multiple
28.69 28.69 12.23 4.91 11.80
Enterprise Value
59.70M 59.70M 57.77M 58.29M 56.05M
EV to EBITDA
28.69 28.69 12.23 4.91 11.80
EV to Sales
4.40 4.40 2.93 1.27 1.07
EV to Free Cash Flow
36.71 36.71 -13.52 -8.05 5.81
EV to Operating Cash Flow
27.02 27.02 -25.57 -8.12 2.06
Tangible Book Value Per Share
0.69 0.69 0.71 0.71 0.34
Shareholders’ Equity Per Share
0.68 0.68 0.69 0.69 0.34
Tax and Other Ratios
Effective Tax Rate
0.43 0.43 0.15 0.15 0.08
Revenue Per Share
0.94 0.94 1.36 3.16 3.62
Net Income Per Share
<0.01 <0.01 0.06 0.41 0.08
Tax Burden
1.01 1.01 0.78 0.81 0.88
Interest Burden
0.23 0.23 0.76 0.96 0.84
Research & Development to Revenue
0.02 0.02 <0.01 <0.01 0.02
SG&A to Revenue
0.14 0.14 0.13 0.06 0.05
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
34.86 34.86 -2.39 -1.15 22.30
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis